Re: Wang et al.: Preperitoneal single-port transvesical enucleation of the prostate (STEP) for large-volume BPH: One-year follow-up of Qmax, IPSS, and QoL (Urology 2012;80:323-329)

摘要

We appreciate the authors1 attempt to determine the feasibility, safety, and efficacy of the single-port transvesi' cal enucleation of the prostate (STEP) procedure for voluminous benign prostatic hyperplasia. We would like to highlight certain issues related to the practical utility of the STEP procedure among the available surgical treatments of benign prostatic hyperplasia. The technical feasibility of the STEP procedure is well established. Considering the overall outcomes in this series (with a mean prostate volume of about 84 cm~3), including the complication rate (along with conversions) of 44.4%, mean resected prostate volume of about 51 cm3, mean operative time of 161 minutes, and mean postoperative stay of 7 days, holmium laser enucleation of the prostate, bipolar transurethral resection of the prostate, or staged monopolar transurethral resection might be better alternative options for such large glands-serving the same purpose with the potential for fewer complications.